EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures
The European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.
Click on this link for more information.
